Stockscreener 앱 받기
6.83
0.58%
0.02
전일 마감가:
$6.85
열려 있는:
$6.81
하루 거래량:
96,528
Relative Volume:
0.66
시가총액:
$53.09M
수익:
$16.03M
순이익/손실:
$-18.83M
주가수익비율:
-1.9514
EPS:
-3.5
순현금흐름:
$-14.87M
1주 성능:
-6.64%
1개월 성능:
+21.73%
6개월 성능:
-46.00%
1년 성능:
+8.93%
1일 변동 폭
$6.01
$7.01
1주일 범위
$6.01
$8.56
52주 변동 폭
$5.02
$19.49
Electrocore Inc Stock (ECOR) Company Profile
명칭
Electrocore Inc
전화
973-290-0097
주소
200 FORGE WAY, ROCKAWAY
ECOR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ECOR
Electrocore Inc
|
6.7719 | 53.09M | 16.03M | -18.83M | -14.87M | -3.50 |
|
ABT
Abbott Laboratories
|
132.44 | 224.65B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.39 | 151.13B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
381.10 | 139.34B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.62 | 108.80B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.42 | 44.25B | 5.54B | 4.18B | 259.90M | 7.00 |
Electrocore Inc Stock (ECOR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-08-14 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2019-11-14 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-09-26 | 재개 | Cantor Fitzgerald | Neutral |
| 2019-05-30 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2019-05-15 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2019-05-09 | 개시 | Noble Capital Markets | Outperform |
| 2018-09-21 | 개시 | Cantor Fitzgerald | Overweight |
모두보기
Electrocore Inc 주식(ECOR)의 최신 뉴스
electroCore completes acquisition of neurotechnology solution provider NeuroMetrix - Yahoo
electroCore Acquires NeuroMetrix, Expands Pain Management Portfolio By Investing.com - Investing.com Nigeria
NeuroMetrix finalizes acquisition by electroCore - Investing.com Nigeria
NeuroMetrix finalizes acquisition by electroCore By Investing.com - Investing.com South Africa
ElectroCore Completes Merger With NeuroMetrix - marketscreener.com
electroCore Completes Acquisition of NeuroMetrix - Medical Product Outsourcing
Electrocore Completes Acquisition Of Neurometrix - marketscreener.com
Electrocore Completes Merger with NeuroMetrix - TipRanks
electroCore Acquires NeuroMetrix, Expands Pain Management Portfolio - Investing.com Australia
ECOR Completes Merger with NeuroMetrix to Bolster Health Solutio - GuruFocus
electroCore Completes Acquisition of NeuroMetrix, Gaining Access - GuruFocus
ECOR Completes Merger with NeuroMetrix to Bolster Health Solutions | ECOR Stock News - GuruFocus
electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, ... - Bluefield Daily Telegraph
electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies - GlobeNewswire
electroCore's $4.49/Share NeuroMetrix Buyout Expands Chronic Pain Treatment Portfolio - Stock Titan
Geode Capital Management LLC Reduces Position in electroCore, Inc. (NASDAQ:ECOR) - Defense World
electroCore, Inc. Announces Integration of Truvaga Plus with Apple Health App to Enhance Wellness Tracking - Nasdaq
electroCore's Truvaga™ Now Works with the Apple Health app - The Manila Times
electroCore’s Truvaga™ Now Works with the Apple Health app - GlobeNewswire
electroCore to Announce First Quarter March 31, 2025 Financial Results on Wednesday, May 7, 2025 - GlobeNewswire
Press Release Distribution & PR Platform - ACCESS Newswire
The Future of Vagus Nerve Stimulation Market Growth, Innovations, and Key Trends - newstrail.com
electroCore (NASDAQ:ECOR) Shares Up 14.6% – Here’s What Happened - Defense World
Vagus Nerve Stimulators Market Set to Witness Significant - openPR.com
ElectroCore (ECOR) Reports Positive Outcomes for Traumatic Brain Injury Treatment | ECOR Stock News - GuruFocus
gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Shown to be Effective in Treating Concussive Symptoms Associated with Mild Traumatic Brain Injuries - The Manila Times
electroCore announces new data presented on nVNS - TipRanks
electroCore, Inc. Reports Positive Data on gammaCore® for Treating Concussive Symptoms in Mild Traumatic Brain Injury at 2025 IBIA World Congress - Nasdaq
gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Shown - GlobeNewswire
Breakthrough Study: Non-Invasive Brain Treatment Relieves 22 Concussion Symptoms in Major Clinical Trial - Stock Titan
electroCore to Participate at the Planet MicroCap Showcase - GlobeNewswire
Vagus Nerve Stimulators Market Deep Research Report with - openPR.com
Electrocore at 24th Annual Needham Virtual Healthcare Conference: Strategic Expansion Plans - Investing.com Australia
ElectroCore stock hits 52-week low at $5.3 amid challenges - Investing.com
ElectroCore stock hits 52-week low at $5.3 amid challenges By Investing.com - Investing.com South Africa
electroCore appoints new independent accounting firm By Investing.com - Investing.com Australia
electroCore appoints new independent accounting firm - Investing.com
electroCore Named One of The Americas’ Fastest Growing Companies by the Financial Times - GlobeNewswire
Financial Times Names electroCore #16 Fastest-Growing Healthcare Company in Americas - Stock Titan
Vagus Nerve Stimulators Market Size, Growth Trends and Report - openPR.com
electroCore to Participate at the Needham Virtual Healthcare Conference - The Manila Times
electroCore Showcases Breakthrough Bioelectronic Medicine Platform: CEO Headlines Needham Conference - Stock Titan
NeuroMetrix, Inc. SEC 10-K Report - TradingView
electroCore secures new VA contract through 2030 - Investing.com India
electroCore secures new VA contract through 2030 By Investing.com - Investing.com UK
electroCore Extends VA Contract for Five Years - GlobeNewswire
electroCore Wins Massive VA Deal While 585 Others Get Cut - Stock Titan
Electrocore Inc (ECOR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Electrocore Inc 주식 (ECOR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Goldberger Daniel S | Chief Executive Officer |
Mar 17 '25 |
Buy |
8.59 |
1,000 |
8,590 |
290,565 |
| Errico Thomas J. | Director |
Mar 17 '25 |
Buy |
8.10 |
6,000 |
48,585 |
256,401 |
| Errico Thomas J. | Director |
Aug 15 '24 |
Buy |
6.12 |
5,000 |
30,595 |
233,818 |
| GANDOLFO JOHN P | Director |
Jun 13 '24 |
Buy |
6.43 |
1,000 |
6,430 |
50,704 |
| Goldberger Daniel S | Chief Executive Officer |
Jun 05 '24 |
Buy |
6.43 |
38,505 |
247,587 |
249,565 |
9.59%
0.04%
자본화:
|
볼륨(24시간):